Omnicell (OMCL) Competitors

HealthStream (NASDAQ:HSTM) and Omnicell (NASDAQ:OMCL) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings.

Do analysts prefer HSTM or OMCL?

HealthStream presently has a consensus target price of $31.50, indicating a potential upside of 11.78%. Omnicell has a consensus target price of $44.83, indicating a potential upside of 40.52%. Given Omnicell's higher probable upside, analysts clearly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Omnicell	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

Does the MarketBeat Community favor HSTM or OMCL?

Omnicell received 45 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.75% of users gave Omnicell an outperform vote while only 66.43% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
HealthStream	Outperform Votes 463 66.43%	Underperform Votes 234 33.57%
Omnicell	Outperform Votes 508 66.75%	Underperform Votes 253 33.25%

Do institutionals and insiders hold more shares of HSTM or OMCL?

69.6% of HealthStream shares are owned by institutional investors. Comparatively, 97.7% of Omnicell shares are owned by institutional investors. 20.5% of HealthStream shares are owned by insiders. Comparatively, 2.5% of Omnicell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more risk and volatility, HSTM or OMCL?

HealthStream has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Does the media favor HSTM or OMCL?

In the previous week, HealthStream had 2 more articles in the media than Omnicell. MarketBeat recorded 6 mentions for HealthStream and 4 mentions for Omnicell. HealthStream's average media sentiment score of 1.51 beat Omnicell's score of 1.02 indicating that HealthStream is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthStream	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Omnicell	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is HSTM or OMCL more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.84%	5.67%	3.91%
Omnicell	1.13%	3.82%	2.07%

Which has stronger earnings & valuation, HSTM or OMCL?

HealthStream has higher earnings, but lower revenue than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$292.37M	2.94	$15.21M	$0.63	44.73
Omnicell	$1.14B	1.32	$12.53M	$0.46	69.36

Summary

HealthStream beats Omnicell on 11 of the 19 factors compared between the two stocks.